Big Fed buying tames the mortgage basis
admin | March 27, 2020
This document is intended for institutional investors and is not subject to all of the independence and disclosure standards applicable to debt research reports prepared for retail investors.
The Fed has taken dramatic action to support MBS markets struggling to deal with the economic effects of the coronavirus. The Fed started adding MBS on March 16 and vastly increased its purchases starting March 20. Earlier the Fed had allowed its MBS portfolio to pay down and only bought more than a small amount when amortization and prepayment exceeded $20 billion a month. The latest round of heavy buying has helped substantially calm the market, tightening the nominal basis by more than 100 bp and bringing it closer to typical levels.
The Fed on March 15 initially committed to buying at least $200 billion MBS over an unspecified timeframe. The central bank bought $17.4 billion MBS over the first three days of the following week, which proved insufficient to calm MBS markets. Purchases increased to $14.4 billion on March 19 and to $35.8 billion on March 20. On March 23, the Fed announced purchases of MBS in whatever quantities necessary to support smooth functioning of the market, and later signaled a target of $50 billion per day. However, purchases over recent sessions averaged roughly $35.5 billion per day (Exhibit 1).
Exhibit 1: The Fed has purchased $210 billion MBS in 9 days ($ mm)
Source: New York Fed, Amherst Pierpont Securities
The Fed has focused on buying 30-year UMBS but has also included a substantial amount of G2SF and FNCI contracts as well. More than 40% of the purchases were for April TBA with non-standard T+3 settlement. So far the Fed has only purchased April and May TBA contracts, with April accounting for 59% of all purchases.
The buying has had the intended effect. Prior to March, the basis was generally range bound between 80 bp and 100 bp but peaked at nearly 200 bp on March 19. The Fed’s massive buying program has lowered the basis to nearly 100 bp, just slightly above the pre-crisis range.
Exhibit 2: The mortgage basis tightened dramatically due to Fed buying this week
Source: Yield Book, Amherst Pierpont Securities
This amount of buying has erased a significant chunk of the quantitative easing undertaken by the Fed. The MBS portfolio was roughly $1.78 trillion in March 2018 and had fallen to roughly $1.37 trillion in March of 2020. The Fed has conducted this buying program at a record pace. The portfolio paid down $410 billion over the course of two years and half that amount has been re-purchased over the last nine days. The current pace also surpasses buying following the 2008 financial crisis—the Fed’s MBS portfolio posted its largest month of growth in February 2009, adding $167 billion in settled holdings as a result of a full month of purchase activity. The Fed looks set to blow through that number next month.
1 (646) 776-7714
This material is intended only for institutional investors and does not carry all of the independence and disclosure standards of retail debt research reports. In the preparation of this material, the author may have consulted or otherwise discussed the matters referenced herein with one or more of SCM’s trading desks, any of which may have accumulated or otherwise taken a position, long or short, in any of the financial instruments discussed in or related to this material. Further, SCM may act as a market maker or principal dealer and may have proprietary interests that differ or conflict with the recipient hereof, in connection with any financial instrument discussed in or related to this material.
This message, including any attachments or links contained herein, is subject to important disclaimers, conditions, and disclosures regarding Electronic Communications, which you can find at https://portfolio-strategy.apsec.com/sancap-disclaimers-and-disclosures.
Copyright © 2023 Santander US Capital Markets LLC and its affiliates (“SCM”). All rights reserved. SCM is a member of FINRA and SIPC. This material is intended for limited distribution to institutions only and is not publicly available. Any unauthorized use or disclosure is prohibited.
In making this material available, SCM (i) is not providing any advice to the recipient, including, without limitation, any advice as to investment, legal, accounting, tax and financial matters, (ii) is not acting as an advisor or fiduciary in respect of the recipient, (iii) is not making any predictions or projections and (iv) intends that any recipient to which SCM has provided this material is an “institutional investor” (as defined under applicable law and regulation, including FINRA Rule 4512 and that this material will not be disseminated, in whole or part, to any third party by the recipient.
The author of this material is an economist, desk strategist or trader. In the preparation of this material, the author may have consulted or otherwise discussed the matters referenced herein with one or more of SCM’s trading desks, any of which may have accumulated or otherwise taken a position, long or short, in any of the financial instruments discussed in or related to this material. Further, SCM or any of its affiliates may act as a market maker or principal dealer and may have proprietary interests that differ or conflict with the recipient hereof, in connection with any financial instrument discussed in or related to this material.
This material (i) has been prepared for information purposes only and does not constitute a solicitation or an offer to buy or sell any securities, related investments or other financial instruments, (ii) is neither research, a “research report” as commonly understood under the securities laws and regulations promulgated thereunder nor the product of a research department, (iii) or parts thereof may have been obtained from various sources, the reliability of which has not been verified and cannot be guaranteed by SCM, (iv) should not be reproduced or disclosed to any other person, without SCM’s prior consent and (v) is not intended for distribution in any jurisdiction in which its distribution would be prohibited.
In connection with this material, SCM (i) makes no representation or warranties as to the appropriateness or reliance for use in any transaction or as to the permissibility or legality of any financial instrument in any jurisdiction, (ii) believes the information in this material to be reliable, has not independently verified such information and makes no representation, express or implied, with regard to the accuracy or completeness of such information, (iii) accepts no responsibility or liability as to any reliance placed, or investment decision made, on the basis of such information by the recipient and (iv) does not undertake, and disclaims any duty to undertake, to update or to revise the information contained in this material.
Unless otherwise stated, the views, opinions, forecasts, valuations, or estimates contained in this material are those solely of the author, as of the date of publication of this material, and are subject to change without notice. The recipient of this material should make an independent evaluation of this information and make such other investigations as the recipient considers necessary (including obtaining independent financial advice), before transacting in any financial market or instrument discussed in or related to this material.